Health HTG Expands Patent Portfolio with New Canadian Patent for its Nuclease Protection Methods for Detection of Nucleotide Variants December 30, 2020
Health Bionano Genomics Granted 180-Day Extension by Nasdaq to Regain Compliance with Bid Price Rule December 30, 2020
Health iCAD Announces Renowned Neuro-Oncologist Santosh Kesari, MD, PhD to Lead Post-Market Study for Treatment of Recurrent Glioblastoma (GBM) with FDA-cleared Xoft Brain IORT Technology to Support Clinical Adoption December 29, 2020
Health Assertio Announces Transfer of Listing from Nasdaq Global Select Market to Nasdaq Capital Market December 29, 2020
Health FINAL DEADLINE IMMINENT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Neovasc Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm December 29, 2020
Health ICPT & NVCN Deadlines: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders of Class Actions and Encourages Investors to Contact the Firm December 29, 2020
Health NVCN FINAL DEADLINE ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Neovasc Inc. Investors of Important January 5 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – NVCN December 28, 2020
Search
